Type 2 Diabetes & Cardiovascular Risk
An investigational therapy for adults with Type 2 diabetes and elevated cardiovascular risk markers.
- Ages 35–75
- 12 months
- On-site & remote visits
An investigational therapy for adults with Type 2 diabetes and elevated cardiovascular risk markers.
A new biologic treatment evaluating reduction in asthma exacerbations over 24 weeks.
Phase III evaluation of a once-daily oral therapy for adults with active rheumatoid arthritis.
A non-opioid investigational compound for the prevention of episodic migraine.
Investigational therapy for adults with BMI 30+ exploring sustained weight management.
Topical investigational treatment for moderate plaque psoriasis affecting daily life.
Add your name to our private list and we'll reach out when something matches your profile.
Get notified